Welcome to LookChem.com Sign In|Join Free

CAS

  • or

5040-09-5

Post Buying Request

5040-09-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5040-09-5 Usage

Description

1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose, with the CAS number 5040-09-5, is a white crystalline solid compound that is utilized in organic synthesis. It is a derivative of D-glucopyranose, a monosaccharide, where four hydroxyl groups are acetylated, and the third carbon is deoxygenated.

Uses

Used in Organic Synthesis:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as an intermediate in the synthesis of various organic compounds for [application reason] its unique structural features that allow for further chemical modifications and functionalization.
Used in Pharmaceutical Industry:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as a building block in the development of complex carbohydrate-based drugs for [application reason] its ability to form specific interactions with biological targets, such as receptors and enzymes.
Used in Chemical Research:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used as a research tool in the study of carbohydrate chemistry and biochemistry for [application reason] its distinctive properties that can provide insights into the structure-function relationships of carbohydrates.
Used in Material Science:
1,2,4,6-Tetra-O-acetyl-3-deoxy-D-glucopyranose is used in the development of novel materials with specific properties, such as stimuli-responsive hydrogels or drug delivery systems, for [application reason] its potential to form complex architectures and interactions with other molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 5040-09-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,0,4 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 5040-09:
(6*5)+(5*0)+(4*4)+(3*0)+(2*0)+(1*9)=55
55 % 10 = 5
So 5040-09-5 is a valid CAS Registry Number.

5040-09-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name [(2R,3S,5R)-3,5,6-triacetyloxyoxan-2-yl]methyl acetate

1.2 Other means of identification

Product number -
Other names tetraacetate-3-deoxy glucose

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5040-09-5 SDS

5040-09-5Relevant articles and documents

Synthesis of 1,5-Anhydro-D-fructose derivatives and evaluation of their inflammasome inhibitors

Goto, Kohtaro,Ideo, Hiroko,Tsuchida, Akiko,Hirose, Yuriko,Maruyama, Ikuro,Noma, Satoshi,Shirai, Takashi,Amano, Junko,Mizuno, Mamoru,Matsuda, Akio

supporting information, p. 3763 - 3772 (2018/07/13)

Synthesis of several 1,5-Anhydro-D-fructose (1,5-AF) derivatives to evaluate inhibitory activities of the inflammasome was carried out. Recently, 1,5-AF reported to suppress the inflammasome, although with only low activity. We focused on the hydration of

HALOGENATED DIDEOXY SUGAR DERIVATES, PREPARATION METHOD AND APPLICATION THEREOF

-

Page/Page column 7, (2012/11/13)

A halogenated dideoxy sugar derivative, having the following general structure I wherein X is halogen, R1 and R2 are H or Br; R3 and R4 are OH or OAc. The compounds 1-14 of the current invention has strong inhib

Development of carbohydrate-derived inhibitors of acid sphingomyelinase

Roth, Anke G.,Redmer,Arenz, Christoph

supporting information; experimental part, p. 939 - 944 (2010/05/02)

The acid sphingomyelinase is an emerging drug target, especially for inflammatory lung diseases. Presently, there are no directly-acting potent inhibitors available for cell-based studies. The potent inhibitor phosphatidylinositol-3,5-bisphosphate (PtdIns3,5P2) is not only unsuited for cell culture studies, but also does not provide hints for further structural improvements. In the SAR study described here, we replaced the inositolphosphate moiety by a carbohydrate derivative and the phosphatidic acid residue by an alkylsulfone ester. The resulting compound is more active than its parent compound and offers new means for further structural modification.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5040-09-5